To study the effect of COVID‐19 vaccination on glucose control, we first designed a study to evaluate the changes in glucose control and insulin sensitivity in healthy mice that received the mRNA COVID‐19 vaccine (BNT162b2) weekly (Figure 1A). The gene discussed is INS; the disease is COVID-19.